Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Acta Chir Belg ; 113(1): 8-13, 2013.
Article in English | MEDLINE | ID: mdl-23550462

ABSTRACT

BACKGROUND: Obstructive jaundice is one of the most important surgical causes of childhood jaundices. The aim of this study is to investigate effects of ginger (Gingiber officinalis) extracts on liver damage in experimental obstructive jaundice produced by main bile duct ligation. MATERIALS AND METHODS: Forty two Wistar-albino rats were randomly allocated into 7 groups (n = 6). Nothing was performed in the control (C) group. Only laparatomy was performed in the sham (Sh) group. The ginger 1 and 2 (G1 and G2) groups received only 100 and 200 mg/kg/day doses of ginger extract for 1 week orally. In study group, common bile duct ligation was done. In treatment 1 and 2 (T1 and T2) groups common bile duct ligation was followed by administration of 100 and 200 mg/kg/day doses of ginger extract for 1 week orally from the third post operative day, respectively. Blood samples and liver were harvested in order to evaluate the serum aspartate aminotransferase (AST), alanine amino transferase (ALT), gama glutamyltransferase (GGT), total bilirubin (bil), superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA) and liver tissue SOD, GSH, MDA levels and liver apoptosis. Results were analyzed by Mann-Whitney U test statistically. RESULTS: Ginger administration did not result in any differences of serum or tissue levels of the studied parameters and liver apoptosis between the groups statistically (except AST levels in group T2). Tissue GSH and serum SOD levels were only mildly increased in groups receiving ginger alone. CONCLUSIONS: There is no evidence for protective, inhibitive and decreasing effects of ginger extract on liver injury in experimental obstructive jaundice with these findings.


Subject(s)
Jaundice, Obstructive/drug therapy , Liver/drug effects , Phytotherapy , Plant Extracts , Zingiber officinale , Animals , Bile Ducts/surgery , Disease Models, Animal , Humans , Ligation , Liver/enzymology , Liver/pathology , Rats , Rats, Wistar , Superoxide Dismutase/metabolism
3.
J Int Med Res ; 38(1): 187-94, 2010.
Article in English | MEDLINE | ID: mdl-20233528

ABSTRACT

This study investigated the effect of interferon alpha2b on chlorhexidine gluconate (CH)-induced peritoneal fibrosis (PF) in rats and assessed peritoneal tissue levels of metalloproteinase (MMP)-2 and tissue inhibitors of metalloproteinases (TIMP)-2. Wistar albino rats (n = 8 per group) were treated as follows: control group, 3 ml/day of 0.9% saline intra-peritoneally for 28 days; CH group, 0.1% CH (200 g[3 ml]/day) in 15% ethanol and 0.9% saline intra-peritoneally for 28 days; CH + interferon (IFN) group, CH (as above) plus pegylated IFN-alpha2b 1.5 mug/kg per week subcutaneously on days 0, 7, 14, 21 and 28; IFN group, pegylated IFN-alpha2b (as above). Parietal peritoneum samples were obtained from the left anterior abdominal wall after 35 days. Parietal thickness, degree of vascular proliferation and inflammation, and MMP-2 and TIMP-2 levels were determined. The mean peritoneal thicknesses of the control, CH, CH + IFN and IFN groups were 7.02 +/- 3.89, 156.86 +/- 29.13, 59.88 +/- 22.1, 9.27 +/- 2.03 mum, respectively. Pegylated IFN-alpha2b decreased CH-induced expression of MMP-2 in the parietal peritoneum, but had no effect on TIMP-2 levels. Further studies are needed to determine the optimal dosage and duration for pegylated IFN-alpha2b treatment.


Subject(s)
Biomarkers/metabolism , Interferon-alpha/pharmacology , Matrix Metalloproteinase 2/metabolism , Peritoneal Fibrosis/drug therapy , Peritoneum/drug effects , Polyethylene Glycols/pharmacology , Tissue Inhibitor of Metalloproteinase-2/metabolism , Animals , Anti-Infective Agents/toxicity , Antiviral Agents/pharmacology , Chlorhexidine/analogs & derivatives , Chlorhexidine/toxicity , Disease Models, Animal , Drug Carriers , Interferon alpha-2 , Male , Peritoneal Fibrosis/chemically induced , Peritoneal Fibrosis/enzymology , Peritoneum/enzymology , Rats , Rats, Wistar , Recombinant Proteins
4.
Clin Exp Dermatol ; 32(6): 709-15, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17953639

ABSTRACT

BACKGROUND: Cutaneous injury causes a depression in antioxidant status, as reactive oxygen species (ROS) are produced in response to injury. AIM: To determine the effects of caffeic acid phenethyl ester (CAPE), an antioxidant and anti-inflammatory agent, on wound healing in rats. METHODS: In total, 40 male rats were divided into two groups: one group treated with CAPE (n = 20) and a second untreated control group (n = 20). A linear full-thickness incision was performed on the back of each rat and sutured. After incision, CAPE was given to the treatment group and saline to the control group. On days 1, 3, 7 and 14, five animals in each group were killed, and wound tissues dissected for biochemical and histopathological analysis. RESULTS: Wound tissues showed a significant increase in glutathione and nitric oxide levels, and a significant decrease in malondialdehyde levels and superoxide dismutase levels in the CAPE group compared with the control group. Histopathology of the wound tissues displayed rapid epithelium development in the CAPE group compared with the control group. CONCLUSION: This study has demonstrated that CAPE partly accelerates full-thickness wound healing by its antioxidant and ROS-scavenging capabilities.


Subject(s)
Antioxidants/pharmacology , Caffeic Acids/pharmacology , Oxidative Stress/drug effects , Phenylethyl Alcohol/analogs & derivatives , Skin/injuries , Wound Healing/drug effects , Animals , Disease Models, Animal , Drug Evaluation, Preclinical , Free Radical Scavengers/pharmacology , Glutathione/metabolism , Male , Malondialdehyde/metabolism , Nitric Oxide/metabolism , Phenylethyl Alcohol/pharmacology , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Skin/metabolism , Skin/pathology , Superoxide Dismutase/metabolism
5.
Clin Exp Allergy ; 32(8): 1170-3, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12190654

ABSTRACT

OBJECTIVE: This study aimed to investigate the rate of occupational sensitization to horse hair in grooms and whether occupational exposure to horse hair increases respiratory and allergic symptoms and affects lung function in grooms or not. METHODS: This is a cross-sectional study. Two hundred grooms were randomly selected among 1000 grooms working in Veliefendi Hippodrome of Istanbul. One hundred and twenty-five subjects agreed to enter the study. Ninety-two workers who worked in the different parts of this hippodrome enrolled as the control group. A detailed questionnaire including respiratory and allergic symptoms was filled in, physical examination, skin prick tests and pulmonary function tests were performed. RESULTS: Sensitization to horse hair was 12.8% in grooms and 4.3% in controls. The difference was statistically significant (P = 0.0035). Asthma was found in 14.4% of the grooms and 5.4% of the controls, allergic rhinitis in 42.4% of the grooms and 18.4% of the controls, allergic conjunctivitis in 35.2% of the grooms and 15.2% of the controls, and allergic skin diseases in 32.8% of the grooms and 13% of the controls. The differences were statistically significant (P = 0.043, P = 0.0002, P = 0.001 and P = 0.0008, respectively). The means of FEV1, FEV1/FVC and FVC parameters were significantly lower in the groom group (P = 0.006, P = 0.001 and P = 0.003, respectively). In the multivariate analysis, being in the groom group and working years were found to be predictive factors for impairments of lung function (P < 0.001 and P = 0.002, respectively). CONCLUSION: Occupational exposure to horse increases the sensitization to horse hair, induces asthma and allergic symptoms and also impairs lung functions.


Subject(s)
Air Pollutants, Occupational/adverse effects , Allergens/adverse effects , Animal Husbandry , Horses , Hypersensitivity/immunology , Occupational Diseases/immunology , Adolescent , Adult , Aged , Animals , Asthma/immunology , Asthma/physiopathology , Case-Control Studies , Conjunctivitis, Allergic/immunology , Conjunctivitis, Allergic/physiopathology , Cross-Sectional Studies , Dermatitis, Allergic Contact/immunology , Dermatitis, Allergic Contact/physiopathology , Hair/immunology , Humans , Hypersensitivity/physiopathology , Lung/physiopathology , Male , Middle Aged , Multivariate Analysis , Occupational Diseases/physiopathology , Respiratory Function Tests , Rhinitis, Allergic, Perennial/immunology , Rhinitis, Allergic, Perennial/physiopathology , Time Factors
6.
Br J Ophthalmol ; 71(5): 387-90, 1987 May.
Article in English | MEDLINE | ID: mdl-3580358

ABSTRACT

Eleven separate three-month courses of cyclosporin A, an oral solution 10 mg/kg/day, were administered to eight patients with Behçet's disease with sight-threatening posterior uveitis. It was found to be effective in arresting the inflammatory activity in the eye as well as the mucocutaneous lesions of Behçet's disease. Improvement in visual acuity was observed within one week of starting therapy. Severe exacerbations in the ocular and mucocutaneous lesions occurred on withdrawal of the drug. At this dosage side effects included hirsutism in all women, and a slight rise of serum bilirubins in two patients and of blood urea in one patient. The latter two conditions responded rapidly to dose adjustment.


Subject(s)
Behcet Syndrome/drug therapy , Cyclosporins/therapeutic use , Adult , Cyclosporins/administration & dosage , Cyclosporins/adverse effects , Female , Hirsutism/chemically induced , Humans , Male , Skin Tests , Substance Withdrawal Syndrome , Uveitis/drug therapy , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...